About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 483 record(s)
Req # A-2023-00021
Provide the following briefing documents prepared in March 2023: BN0015245 New Mandatory Request for Information.Organization: Statistics Canada
June 2023
Req # A-2023-00032
Job descriptions for all staff in the Data Science Division at Statistics Canada. The job descriptions should indicate classification of the employees. The job descriptions should include the following titles, as well as any others not listed. - Director (Data Science Division) - Assistant Director - Analyst - Senior Advisor - Chief - Chief, Development and Management - Unit Head - Enterprise Portfolio Manager - Unit Head, Senior Analyst - Data Scientist - Unit Head, Senior Economist - Senior Economist - Senior Analyst - Lead Data Scientist - Portfolio & Outreach Analyst - Account Executive - Senior Data Scientist - Student, Co-operative Program - Methodologist - Support technician - Coordinator - FSWEP studentOrganization: Statistics Canada
June 2023
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2022-00403
Provide copies of documents showing all costs associated with the planning and launch of the most recent cycle of the Canadian Health Measures SurveyOrganization: Statistics Canada
May 2023
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2022-05126
Provide all emails with keyword “ATIP” from May 1, 2021 to February 23, 2022.Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2023-11914
Number of instances in which the ATIP unit used section 20(6) (the public interest override) of the Access to Information Act, as tallied by the documentation retained in accordance with the Manual. No time limit; assess based on period of available documentation (and please indicate this period).Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2021-24940
Provide all emails sent to/from Tanya Potashnik from May 1, 2021, to December 19, 2021. Exclude media scans.Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2022-00407
We would like to request data on drug metabolites in wastewater from Statistics Canada. We are particularly interested in obtaining access to monthly data detecting presence of drugs in wastewater in Montreal from program inception to the most recent available. Although our primary interest is opioid metabolites, we would also be grateful to receive data relating to stimulants (methamphetamine and cocaine).Organization: Statistics Canada
April 2023
Req # A-2023-09059
Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th, 2022. This request runs from October 6th to December 7th, 2022. If Health Canada or any other federal government department provided comments outside of the consultation process I would like a copy of those comments as well. This part of the request also runs from October 6th to December 7th, 2022.Organization: Patented Medicine Prices Review Board Canada
March 2023